Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
What Is the Impact of Vitamin D Supplementation on Glycemic Control in People With Type-2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trails Publisher Pubmed



Farahmand MA1, 2 ; Daneshzad E3 ; Fung TT4, 5 ; Zahidi F1 ; Muhammadi M6 ; Bellissimo N7 ; Azadbakht L1, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), PO BOX: 1416643931, Tehran, Iran
  2. 2. Public Health Faculty, Kabul University of Medical Science (KUMS), Kabul, Afghanistan
  3. 3. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  4. 4. Department of Nutrition, Harvard TH Chan School of Public Health, Boston, United States
  5. 5. Department of Nutrition, Simmons University, Boston, MA, United States
  6. 6. Critical Nursing Care Department, Kabul University of Medical Science (KUMS), Kabul, Afghanistan
  7. 7. School of Nutrition, Toronto Metropolitan University, Toronto, ON, Canada
  8. 8. Diabetes Research Centre, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: BMC Endocrine Disorders Published:2023


Abstract

Background: There is conflicting evidence on the effect of vitamin D on glycemic control. Therefore, in the current meta-analyses, we aimed to assess the effect of vitamin D supplementation on the glycemic control of type 2 diabetes (T2D) patients. Methods: We conducted a comprehensive search in electronic databases including; PubMed/Medline, Web of Science, Scopus, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and NIH’s Clinical Trials Registry, from the inception of each database up to January first, 2021. Results: A total of 46 randomized controlled trials (RCTs) consisting of 2164 intervention subjects and 2149 placebo controls were included in this meta-analysis. Pooled analyses for HbA1c showed a significant change between the intervention and placebo group, the weighted mean difference (WMD)(95% confidence interval(CI)) was -0.20%(-0.29, -0.11) with P < 0.001. Analyses for assessing changes in FPG found a significant reduction in the intervention group after vitamin D supplementation, the WMD (95%CI) was -5.02 mg/dl (-6.75,-3.28) with P < 0.001. The result of pooled analyses for HOMA-IR revealed a significant change between the intervention and control group, the WMD (95%CI) was -0.42(-0.76, -0.07) with P = 0.019. The subgroup analyses showed the most efficacy in a higher dose and short intervention period and in subjects with deficient vitamin D status. Conclusion: Vitamin D supplementation might be beneficial for the reduction of FPG, HbA1c, and HOMA-IR in type 2 diabetes patients with deficient vitamin D status. This effect was especially prominent when vitamin D was given in large doses and for a short period of time albeit with substantial heterogeneity between studies and a probability of publication bias. © 2023, The Author(s).
Experts (# of related papers)
Other Related Docs
30. Effect of Vitamin D3 Supplementation on Blood Pressure in Adults: An Updated Meta-Analysis, Nutrition# Metabolism and Cardiovascular Diseases (2016)
36. High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome, International Journal of Hematology-Oncology and Stem Cell Research (2017)
38. Meal Replacements on Obesity and Leptin: A Systematic Review and Meta-Analysis, Reviews in Endocrine and Metabolic Disorders (2025)